NCT03920579View on ClinicalTrials.gov

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
HypertensionDyslipidemias
Interventions
DRUG

CKD-386 formulation 1

A single oral dose of 1 tablet under fasting conditions for each period

DRUG

CKD-386 formulation 2

A single oral dose of 1 tablet under fasting conditions for each period

DRUG

D326, D337 and D013

A single oral dose of 3 tablets(D326, D337 and D013) under fasting conditions for each period

Trial Locations (1)

21565

RECRUITING

Gachon University Gil Medical Center, Incheon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03920579 - A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter